9/1/2010

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

5/17/2010

Data Continue to Demonstrate Value of NeuroStar TMS Therapy as a Proven Treatment for Patients Battling Difficult-to-Treat Depression

5/6/2010

Important TMS Therapy Study Results

2/18/2010

Neuronetics Advances Commercialization of New Depression Therapy; Hires Kim Tietz as Vice President, Marketing

11/12/2009

NeuroStar TMS Therapy^® Receives Prestigious Popular Science Award

11/9/2009

Neuronetics Adds former CEO of VNUS Medical Technologies to Board of Directors

8/31/2009

Neuronetics, Inc. Raises $30 Million in Series D Financing

5/20/2009

Study Shows NeuroStar TMS Therapy^® Improved Key Elements of Cognition in Patients with Major Depressive Disorder

4/20/2009

NeuroStar TMS Therapy Recipient of Medical Design Excellence Award

11/6/2008

New Study Demonstrates Cost Effectiveness of NeuroStar® TMS Therapy in the Treatment of Depression

10/8/2008

FDA Clears NeuroStar^® TMS Therapy for the Treatment of Depression